Zwie'bak Pharmaceuticals Private Limited
About Zwie'bak Pharmaceuticals Private Limited
Data last updated:
Zwie'bak Pharmaceuticals Private Limited is a private limited company based in Aligarh, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2003PTC028068. Its GSTIN is 09AAACZ1967E1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shailendra Singh and Poonam Singh.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7/69 Phaphala, Aligarh, Uttar Pradesh, India – 202001.
As per the financials filed for FY 2024, the company reported a revenue of ₹77.76 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹7 Lakh (net margin 9%) and EBITDA of ₹9.47 Lakh (EBITDA margin 12.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹12 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zwie'bak Pharmaceuticals Private Limited's registered office is in Aligarh, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address7/69 Phaphala, Aligarh, Uttar Pradesh, India – 202001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zwie'bak Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
Financials of Zwie'bak Pharmaceuticals Private Limited
FY 2025 filings availableZwie'bak Pharmaceuticals Private Limited reported revenue of ₹77.76 Lakh (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 19% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | ||||
| Net Profit Margin | 9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zwie'bak Pharmaceuticals Private Limited
Zwie'bak Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailendra Singh | Director | 29 Jun 2016 | 10 Years 4 Months | Current |
| Poonam Singh | Director | 17 Nov 2003 | 22 Years 11 Months | Current |
Peer comparison
Zwie'bak Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Faith Pharmaceuticals Limited | ₹78.18 Lakh (FY 2025) | 4.0% | New Delhi, Delhi, India | |||
| Medechem Pharmaceuticals (OPC) Private Limited | ₹77.96 Lakh (FY 2025) | -23.0% | New Delhi, Delhi, India | |||
| Russet Therapeutics Private Limited | ₹77.86 Lakh (FY 2023) | 1003.0% | Lalacheruvu, Andhra Pradesh, India | |||
| Zwie'bak Pharmaceuticals Private Limitedthis company | ₹77.76 Lakh (FY 2024) | ₹7 Lakh | 9% | 19.0% | Aligarh, Uttar Pradesh, India | |
| Glamour Pharmaceuticals Private Limited | ₹77.73 Lakh (FY 2024) | -6.0% | Uttar Pradesh, India | |||
| Inara India Pharmaceuticals Private Limited | ₹77.65 Lakh (FY 2022) | 0.0% | Kolkata, West Bengal, India | |||
| Rashvi Bioscience Private Limited | ₹77.64 Lakh (FY 2024) | 5233.0% | Kadi, Gujarat, India | |||
| Medishine Pharmaceuticals Private Limited | ₹77.61 Lakh (FY 2021) | 200.0% | Guwahati, Assam, India |
To see the full peer comparison of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
Auditor
Zwie'bak Pharmaceuticals Private Limited is audited by SUBODH KUMAR AND ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBODH KUMAR AND ASSOCIATES | FY 2021 | 512379C |
Shareholding
The shareholding of Zwie'bak Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jun 2016 | 100036524 | Others | ₹20 Lakh | Open | |
| 27 Jan 2011 | 10265610 | State Bank of India | ₹12 Lakh | Satisfied |
To see the full charge records of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Zwie'bak Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zwie'bak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zwie'bak Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACZ1967E1Z5 | Uttar Pradesh | Active | 01 Aug 2017 |
To see the full GST registrations and return filing status of Zwie'bak Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zwie'bak Pharmaceuticals Private Limited has 3 board changes on record since 2003: 2 appointments and 1 cessation. The latest: Deepak Kumar Singh ceased to be Director on 29 Jun 2016.
Frequently asked questions
Zwie'bak Pharmaceuticals is an active private limited company based in Aligarh, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 November 2003 (23+ years old) and is registered under CIN U24232UP2003PTC028068.
Zwie'bak Pharmaceuticals has 2 current directors:
- Shailendra Singh - Director
- Poonam Singh - Director
The latest financial statements of Zwie'bak Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zwie'bak Pharmaceuticals is 09AAACZ1967E1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Zwie'bak Pharmaceuticals is U24232UP2003PTC028068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zwie'bak Pharmaceuticals was incorporated on 17 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Zwie'bak Pharmaceuticals by revenue are Faith Pharmaceuticals Limited, Medechem Pharmaceuticals (OPC) Private Limited, Russet Therapeutics Private Limited, Glamour Pharmaceuticals Private Limited, Inara India Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Deepak Kumar Singh ceased to be Director on 29 Jun 2016. Shailendra Singh was appointed as Director on 29 Jun 2016. Poonam Singh was appointed as Director on 17 Nov 2003.
The registered office of Zwie'bak Pharmaceuticals is at 769 Phaphala, Aligarh, Uttar Pradesh, India – 202001.
Zwie'bak Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Zwie'bak Pharmaceuticals has open charges of ₹20 Lakh and satisfied charges of ₹12 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
